(c) 2024 PillSync.com

neomycin sulfate 500 mg

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of Neomycin Sulfate Tablets, USP and other antibacterial drugs, Neomycin Sulfate Tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Suppression of Intestinal Bacteria Neomycin Sulfate Tablets, USP are indicated as adjunctive therapy as part of a regimen for the suppression of the normal bacterial flora of the bowel, e.g. preoperative preparation of the bowel. It is given concomitantly with erythromycin enteric-coated base (see DOSAGE AND ADMINISTRATION section) . Hepatic Coma (Portal-Systemic Encephalopathy) Neomycin sulfate has been shown to be effective adjunctive therapy in hepatic coma by reduction of the ammonia-forming bacteria in the intestinal tract. The subsequent reduction in blood ammonia has resulted in neurologic improvement.

xgen pharmaceuticals djb, inc.


1 year ago ROUND WHITE PT 500 neomycin sulfate 500 mg

ROUND WHITE PT 500

1 year ago ROUND WHITE PT 500 neomycin sulfate 500 mg

PT 500 ROUND WHITE

HOW SUPPLIED

NEOMYCIN SULFATE Tablets, USP, 500 mg (equivalent to 350 mg of neomycin base per tablet) are available as round, off-white, unscored tablets, debossed "500" and "PT". Supplied as: NDC 39822-0310-5 as Unit Dose blister packages of 100 tablets (10 strips of 10 tablets each). Store at 20º to 25ºC (68º to 77ºF) [see USP Controlled Room Temperature]. Dispense in tight containers as defined in the USP/NF. Manufactured in Canada. Manufactured for: XGen Pharmaceuticals DJB, Inc. Big flats, NY 14814 Revised: March 2023 NST-PI-04 2000015347 djb logo


More pills like ROUND PT 500












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site